Yanping Li

674 total citations
34 papers, 483 citations indexed

About

Yanping Li is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Yanping Li has authored 34 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cancer Research, 16 papers in Molecular Biology and 14 papers in Oncology. Recurrent topics in Yanping Li's work include Cancer, Hypoxia, and Metabolism (9 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Cancer Cells and Metastasis (5 papers). Yanping Li is often cited by papers focused on Cancer, Hypoxia, and Metabolism (9 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Cancer Cells and Metastasis (5 papers). Yanping Li collaborates with scholars based in China, United States and France. Yanping Li's co-authors include David Z. Qian, Mu‐Shui Dai, Rui Yang, Guanghui Zhang, Hongjuan Cui, Hongtao Xu, Meng Li, Hongyan Wu, Xiu‐Lan Sun and Lihu Zhang and has published in prestigious journals such as Oncogene, Molecules and Biochemical Pharmacology.

In The Last Decade

Yanping Li

32 papers receiving 480 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanping Li China 11 254 218 110 59 50 34 483
Muhammad Tufail China 14 315 1.2× 174 0.8× 125 1.1× 56 0.9× 74 1.5× 57 608
Jung‐Yu Kan Taiwan 15 341 1.3× 226 1.0× 138 1.3× 60 1.0× 74 1.5× 29 561
Kinga A. Kocemba‐Pilarczyk Poland 11 390 1.5× 156 0.7× 170 1.5× 58 1.0× 28 0.6× 24 570
Yanling Sun China 13 348 1.4× 155 0.7× 124 1.1× 132 2.2× 45 0.9× 52 580
Francesca Rosignolo Italy 15 355 1.4× 243 1.1× 124 1.1× 63 1.1× 55 1.1× 19 641
Linfei Hu China 13 268 1.1× 119 0.5× 104 0.9× 43 0.7× 68 1.4× 34 451
Gabriele Romano United States 11 261 1.0× 138 0.6× 196 1.8× 61 1.0× 49 1.0× 18 484
Virginie Quidville France 8 228 0.9× 129 0.6× 88 0.8× 42 0.7× 44 0.9× 10 398
Lei Gan China 13 340 1.3× 225 1.0× 93 0.8× 53 0.9× 57 1.1× 29 544
Zhimin Fan China 15 319 1.3× 181 0.8× 140 1.3× 81 1.4× 106 2.1× 32 566

Countries citing papers authored by Yanping Li

Since Specialization
Citations

This map shows the geographic impact of Yanping Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanping Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanping Li more than expected).

Fields of papers citing papers by Yanping Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanping Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanping Li. The network helps show where Yanping Li may publish in the future.

Co-authorship network of co-authors of Yanping Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yanping Li. A scholar is included among the top collaborators of Yanping Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanping Li. Yanping Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Jiangping, Xin Ou, Feng Shi, et al.. (2025). Peripheral TNF-α and CD8+/CD28+ T Lymphocytes as Alternatives for PD-L1 Prediction in Breast Cancer Tumor Microenvironment: Stratified by Neoadjuvant Therapy. Breast Cancer Targets and Therapy. Volume 17. 627–637.
2.
Tang, Jingyi, Yanping Li, Jilan Chen, et al.. (2025). Artesunate modulates the tumor microenvironment via STAT1/IRF1-mediated TAM repolarization and T cell activation in non-small cell lung cancer. Phytomedicine. 146. 157085–157085. 1 indexed citations
3.
Li, Yanping, Zhaoyang Wang, Xueping Xu, et al.. (2025). Protac synthesized on the basis of azaflavonoid derivatives possesses favorable anti-hepatocellular carcinoma activity. Bioorganic Chemistry. 163. 108687–108687. 1 indexed citations
4.
Wang, Zhao‐Yang, Yanping Li, Jinjin Wang, et al.. (2025). Design and synthesis of isatin derivative payloaded peptide-drug conjugate as tubulin inhibitor against colorectal cancer. European Journal of Medicinal Chemistry. 285. 117276–117276. 1 indexed citations
5.
Fu, Mengxia, Yanping Li, & Jian Wang. (2025). Incidence and Mortality of Colorectal Cancer in Asia in 2022 and Projections for 2050. Journal of Gastroenterology and Hepatology. 40(5). 1143–1156. 2 indexed citations
6.
Li, Xuemei, Yue Xiang, Yanping Li, et al.. (2024). N-glycosylation of SCAP exacerbates hepatocellular inflammation and lipid accumulation via ACSS2-mediated histone H3K27 acetylation. American Journal of Physiology-Gastrointestinal and Liver Physiology. 326(6). G697–G711. 5 indexed citations
7.
Liu, Lu, Yunjie Zhao, Zhenyi Luo, et al.. (2023). Targeting extracellular matrix through phytochemicals: a promising approach of multi-step actions on the treatment and prevention of cancer. Frontiers in Pharmacology. 14. 1186712–1186712. 17 indexed citations
8.
Dong, Xiaolin, et al.. (2023). miR-153-3p suppresses the differentiation and proliferation of neural stem cells via targeting GPR55. Aging. 15(16). 8518–8527. 4 indexed citations
9.
Wang, Xinguang, Zhaoqing Fan, Xing Wang, et al.. (2022). Neoadjuvant endocrine therapy for strongly hormone receptor-positive and HER2-negative early breast cancer: results of a prospective multi-center study. Breast Cancer Research and Treatment. 195(3). 301–310. 8 indexed citations
10.
Wu, Jiangping, Yanjie Zhao, Quan Zhou, et al.. (2022). Consistent expression of PD-L1 in tumor microenvironment with peripheral PD-1/PD-L1 in circulating T lymphocytes of operable breast cancer: a diagnostic test. Diagnostic Pathology. 17(1). 68–68. 5 indexed citations
11.
Wu, Min, et al.. (2022). Screening potential immune signatures for early-stage basal-like/triple-negative breast cancer. World Journal of Surgical Oncology. 20(1). 214–214. 1 indexed citations
12.
Yu, Junhui, Yu Feng, Xin-Bao Li, et al.. (2021). Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastasis from breast cancer: a preliminary report of 4 cases. Gland Surgery. 10(4). 1315–1324. 2 indexed citations
13.
Li, Yanping, et al.. (2021). Effect of postoperative chemotherapy on blood glucose and lipid metabolism in patients with invasive breast cancer. Gland Surgery. 10(4). 1470–1477. 30 indexed citations
14.
Sun, Mingming, Hao Sheng, Tingfeng Wu, et al.. (2021). PIKE-A promotes glioblastoma growth by driving PPP flux through increasing G6PD expression mediated by phosphorylation of STAT3. Biochemical Pharmacology. 192. 114736–114736. 22 indexed citations
15.
Li, Yanping, et al.. (2021). Effect of anthracycline-based postoperative chemotherapy on blood glucose and lipid profiles in patients with invasive breast cancer. Annals of Palliative Medicine. 10(5). 5502–5508. 11 indexed citations
16.
Yang, Rui, Xiuxiu Li, Yanan Wu, et al.. (2020). EGFR activates GDH1 transcription to promote glutamine metabolism through MEK/ERK/ELK1 pathway in glioblastoma. Oncogene. 39(14). 2975–2986. 69 indexed citations
17.
Li, Yanping, et al.. (2020). Molecular Crosstalk Between MYC and HIF in Cancer. Frontiers in Cell and Developmental Biology. 8. 590576–590576. 66 indexed citations
18.
Wang, Shuo, Guoliang Qiao, Xiaoli Wang, et al.. (2019). Functional CD3+CD8+PD1− T Cell Accumulation and PD-L1 Expression Increases During Tumor Invasion in DCIS of the Breast. Clinical Breast Cancer. 19(5). e617–e623. 9 indexed citations
19.
Wang, Yunchao, Tao Sun, Lijun Sheng, et al.. (2018). Overall Survival Benefit from Trastuzumab-Based Treatment in HER2-Positive Metastatic Breast Cancer: A Retrospective Analysis. Oncology Research and Treatment. 41(7-8). 450–455. 15 indexed citations
20.
Yu, Feng, et al.. (2018). Correlation between the intrinsic subtype and diagnostic methods of axillary lymph node metastasis in primary breast cancer. European Journal of Gynaecological Oncology. 39(6). 921–925. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026